Search

everythinglearnresearchcommunity

for

Search:↓

Finasteride and dutasteride are effective for male hair loss and enlarged prostate but may cause reversible sexual side effects.

Dihydrotestosterone and 5α-Reductase play a role in hair loss and prostate health, and finasteride can increase hair growth in men without affecting sperm production, but it doesn't work for postmenopausal women with hair loss.

Hair loss in male pattern baldness is linked to changes in specific genes and proteins that affect hair growth and scalp health.

Wearing headcovers doesn't affect male-pattern hair loss severity.

A genetic test can identify people at risk of male pattern baldness early, allowing for quicker treatment.

Hair loss in male pattern baldness involves muscle degeneration and increased scalp fat.

Some treatments work for common baldness, but there's less evidence for other hair loss types, and more research is needed.

Acne is more common in men with male pattern baldness due to increased hormone levels.

Hormones and genes affect hair growth and male baldness.

Increased PPARGC1α relates to hair thinning in common baldness.

The Miniflap Hair Restoration method effectively restores hair and reduces baldness, but may cause some hair loss and increased baldness in the crown, with the Juri flap method suggested as a quicker, less risky alternative.

There's no significant link between hair loss from male pattern baldness and early heart disease.

Adding cells to fat grafts improves hair regrowth in early baldness, but effects lessen over time.

Cicatricial pattern hair loss is likely advanced common baldness, not a type of lichen planopilaris.

DNA profiling in forensics has improved, but predicting physical traits and ancestry from DNA has limitations and requires ethical consideration.

Increased cell death and reduced cell growth in hair follicles contribute to baldness.

Finasteride 1 mg helps prevent more hair loss in men with male pattern baldness.

The document suggests more research is needed to understand the link between baldness and prostate cancer.

Women with PCOS have higher levels of certain androgens, which are good at predicting excess hair growth.

Minoxidil and finasteride can slow hair loss and stimulate regrowth, but won't restore all lost hair or reverse complete baldness.

Hair loss in males involves inflammation, collagen buildup, and follicle damage, with severity increasing with age and baldness duration.

Men with male pattern baldness had worse COVID-19 symptoms, but early treatment with certain drugs improved outcomes for all.

Early baldness in men may indicate risks for obesity, metabolic syndrome, insulin resistance, and heart disease, similar to women with PCOS. Alopecia areata is often linked with autoimmune diseases and mental health issues. Certain hair disorders are due to genetic issues, and chemotherapy can cause hair loss through specific biological pathways. Iron deficiency's link to hair loss is still disputed.

Men with male pattern baldness have higher blood sugar, bad cholesterol, and ZAG protein levels than healthy men.

Male pattern baldness does not cause an increased risk of prostate cancer.

Finasteride and Dutasteride can improve hair growth in male baldness but may cause temporary sexual dysfunction and possibly affect fertility.

Minoxidil was promising for treating male and female pattern baldness in 1994, but more research on genetics and other treatments was needed.

Women with early-onset baldness should be checked for early bone loss, but bone density doesn't change with baldness severity.

Unified regulations and ethical guidelines are needed for fair use of forensic DNA phenotyping.

Dysregulated lipid metabolism may play a role in male pattern baldness.